Fogarty Announces Awards for Biodiversity-Based Drug Discovery Research
Compounds from natural products continue to be the important sources of completely new chemistry.
ACD/Labs Opens new Office in the UK
The new office in the UK will serve local pharmaceutical, chemical, environmental, and academic markets.
Galapagos and Prolysis Extend Research Collaboration
Prolysis will fund BioFocus research for medicinal chemistry work throughout 2006.
Wyatt Demonstrates Strength in Macromolecular Characterization Solutions
Wyatt will be exhibiting its comprehensive range of products on booth #1944, PittCon 2006.
NIST Releases a Major Upgrade of Mass Spectra Library
The library is an encyclopedic database of "fingerprints" used to identify chemical compounds.
Exelixis and Wyeth Sign License Agreement
The agreement is related to compounds targeting the receptor implicated in metabolic and liver disorders.
DNAPrint Completes Acquistion of Ellipsis Biotherapeutics
Ellipsis Biotherapeutics acquisition strengthens DNAPrint’ position in the diagnostic and clinical patient testing market.
Acumen and deCODE Chemistry Initiate Drug Discovery Research
The target of this programme is to identify potential therapeutic treatments for Alzheimer’s Disease.
Southeast Nebraska Cancer Center Receives Major Research Funding
This funding will allow doctors and researchers to develop effective treatments for cancer patients.
MDL Isentris Platform Selected by LEO Pharma
Discovery informatics architecture enhances R&D productivity by integrating informatics and workflow.